Mona Chitre, PharmD, CGP: Every social determinant of health has the impact and the potential to exacerbate MDD [major depressive disorder]. MDD and social determinants of health have a unique relationship. Social determinants of health can trigger mental health disorders, and mental health disorders can cause someone to make poor life decisions that trigger social determinants of health.
Let’s talk about social determinants of health. I often say it’s anything in your environment that can enable you to thrive, be well, or see a positive future. In the mental health arena, some pop up frequently. In no particular order, one is safe housing. Is there a safe housing option for our members? Are they in a safe community? Are they free of trauma and stress? Food and transportation are some basics. Do they know where their next meal is going to come from? Do they have access to a physician’s office or a pharmacy? Income level is another. Income level has many triggers toward health care disparities in general. It affects health care literacy, access to care, and access to treatment. Is their job secure? Is it a toxic environment? Is it safe? Family relationships [are another factor]. That’s just to name a few. Is there a family support group? Any social determinant of health can trigger a mental health challenge, a mental health crisis, or a mental health disorder.
Jay Weaver, PharmD, MPH: I have to agree with Dr Chitre. Most of the things she outlined were spot on. The only thing I’d add would be some of the nutritional challenges. We’re coming to understand that there’s a link between the foods that we eat and have access to and our sense of well-being. Things like high-calorie foods and high-carbohydrate foods are typically less expensive than higher-quality foods. We also know that the amounts of sugar and other things in those foods can affect our mental well-being. Sometimes food insecurity plays into major depressive disorder in ways that we don’t fully understand.
Transcript edited for clarity.
Social Determinants of Health in MDD: Part 2
Key social determinants of health impacting MDD are discussed by expert payer panelists.
EP: 1.Unmet Needs in Treatment of MDD
EP: 2.MDD Treatment Landscape
EP: 3.Potential Consequences of Recurrent or Poorly Controlled MDD
EP: 4.Burden of Treatment Failure in MDD
EP: 5.Importance of Early Effective Treatment of MDD
EP: 6.Evaluating MDD Treatment Attributes
EP: 7.Considerations for Newly Launched MDD Treatments
EP: 8.Healthcare Disparities Within Major Depressive Disorder
EP: 9.MDD Treatment Disparities Across Patient Populations
EP: 10.Social Determinants of Health in MDD
EP: 11.Impact of COVID-19 on Demand for Mental Health Services
EP: 12.Health Care Disparities Within Major Depressive Disorder (MDD)
EP: 13.MDD Treatment Disparities Across Patient Populations: Part 2
EP: 14.Social Determinants of Health in MDD: Part 2
EP: 15.Population Health Approach in MDD
EP: 16.Factors Affecting MDD Treatment Adherence
EP: 17.Supporting Adherence for Patients with MDD
EP: 18.Aligning MDD Treatment Goals for Payers and Patients
EP: 19.The Impact of Early Effective Treatment in MDD
EP: 20.Key Contributors to Long-term Outcomes for Patients With MDD
Mona Chitre, PharmD, CGP: Every social determinant of health has the impact and the potential to exacerbate MDD [major depressive disorder]. MDD and social determinants of health have a unique relationship. Social determinants of health can trigger mental health disorders, and mental health disorders can cause someone to make poor life decisions that trigger social determinants of health.
Let’s talk about social determinants of health. I often say it’s anything in your environment that can enable you to thrive, be well, or see a positive future. In the mental health arena, some pop up frequently. In no particular order, one is safe housing. Is there a safe housing option for our members? Are they in a safe community? Are they free of trauma and stress? Food and transportation are some basics. Do they know where their next meal is going to come from? Do they have access to a physician’s office or a pharmacy? Income level is another. Income level has many triggers toward health care disparities in general. It affects health care literacy, access to care, and access to treatment. Is their job secure? Is it a toxic environment? Is it safe? Family relationships [are another factor]. That’s just to name a few. Is there a family support group? Any social determinant of health can trigger a mental health challenge, a mental health crisis, or a mental health disorder.
Jay Weaver, PharmD, MPH: I have to agree with Dr Chitre. Most of the things she outlined were spot on. The only thing I’d add would be some of the nutritional challenges. We’re coming to understand that there’s a link between the foods that we eat and have access to and our sense of well-being. Things like high-calorie foods and high-carbohydrate foods are typically less expensive than higher-quality foods. We also know that the amounts of sugar and other things in those foods can affect our mental well-being. Sometimes food insecurity plays into major depressive disorder in ways that we don’t fully understand.
Transcript edited for clarity.
Ibrutinib Shows Similar Efficacy Across Trials in Chronic Lymphocytic Leukemia
May 17th 2024Matching-adjusted indirect comparison methodology was utilized to compare ibrutinib arms across the ALPINE and ELEVATE-RR trials.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Screening Patients With HCC Risk Factors Linked With Reduced Mortality
May 17th 2024A recent study found that screening for hepatocellular carcinoma (HCC) is associated with reduced mortality, highlighting the need to promote HCC screening for patients with known risk factors.
Read More
Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong
December 21st 2023Jun Gong, MD, of Cedars-Sinai Medical Center, discusses the latest data on adagrasib in colorectal cancer, the importance of conducting genomic testing, and more.
Listen
Type 2 Diabetes Associated With Reduced Survival in Patients With CRC
May 17th 2024Patients with colorectal cancer (CRC) had lower 5-year survival if they had type 2 diabetes.
Read More
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Ibrutinib Shows Similar Efficacy Across Trials in Chronic Lymphocytic Leukemia
May 17th 2024Matching-adjusted indirect comparison methodology was utilized to compare ibrutinib arms across the ALPINE and ELEVATE-RR trials.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Screening Patients With HCC Risk Factors Linked With Reduced Mortality
May 17th 2024A recent study found that screening for hepatocellular carcinoma (HCC) is associated with reduced mortality, highlighting the need to promote HCC screening for patients with known risk factors.
Read More
Updates on Adagrasib in CRC and the Importance of Genomic Testing With Dr Jun Gong
December 21st 2023Jun Gong, MD, of Cedars-Sinai Medical Center, discusses the latest data on adagrasib in colorectal cancer, the importance of conducting genomic testing, and more.
Listen
Type 2 Diabetes Associated With Reduced Survival in Patients With CRC
May 17th 2024Patients with colorectal cancer (CRC) had lower 5-year survival if they had type 2 diabetes.
Read More
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More